Authors: Schellens, JHM Dombernowsky, P Cassidy, J Epelbaum, R Dirix, L Cox, EH Wanders, J Calabresi, F Paridaens, R Monfardini, S Wolff, J Loos, WJ Verweij, J Pavlidis, N Hanauske, AR

Citation: Jhm. Schellens et al., Population pharmacokinetics and dynamics in phase II studies of the novel bioreductive alkylating cytotoxic indoloquinone EO9, ANTI-CANC D, 12(7), 2001, pp. 583-590

Authors: Boccardo, F Rubagotti, A Canobbio, L Galligioni, E Sorio, R Lucenti, A Cognetti, F Ruggeri, E Landonio, G Baiocchi, C Besana, C Citterio, G De Rosa, M Calabresi, F

Citation: F. Boccardo et al., Interleukin-2, interferon-alpha and interleukin-2 plus interferon-alpha inrenal cell carcinoma. A randomized phase II trial, TUMORI, 84(5), 1998, pp. 534-539